RESEARCH TRIANGLE PARK, N.C., Feb. 21, 2019 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (GTHX), a clinical-stage oncology company, today announced that it will host a webcast and conference call to report financial results for the fourth quarter and full-year 2018 on Thursday, February 28, 2019 at 4:30 p.m. ET.
The live call may be accessed by dialing 866-763-6020 (domestic) or 210-874-7713 (international) and entering the conference code: 2698949. A live and archived webcast will be available on the Events & Presentations page of the company’s website: www.g1therapeutics.com.
G1 will provide an update on its clinical-stage oncology drug candidates at an Investor Day on March 6, 2019. The company will announce additional details on the event, including webcast information, on February 27.
About G1 Therapeutics
G1 Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and delivery of innovative therapies that improve the lives of those affected by cancer. The company is advancing three clinical-stage programs, trilaciclib, lerociclib and G1T48, that are designed to enable more effective combination treatment strategies and improve patient outcomes across multiple oncology indications.
G1 is based in Research Triangle Park, NC. For additional information, please visit www.g1therapeutics.com and follow us on Twitter @G1Therapeutics.
Head of Investor Relations/Public Relations